Back

Impact of sacubitril valsartan on sleep apnea in heart failure patients with reduced ejection fraction (SV-SLEEP): a systematic review and meta-analysis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: HFrEF: pathophysiological insights Heart Failure with Reduced Ejection Fraction (HFrEF) ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Fahad Al-Kindi

Sultan Qaboos University Hospital, University Medical City, Muscat (Oman)

8 More presentations in this session

Presentation thumbnail
Risk stratification with ultrasound markers of congestion in advanced heart failure
Professor H. Sisakian (Yerevan, AM)
Abstract Slides Video
Presentation thumbnail
Cardiac reverse remodeling induced by cardiac resynchronization therapy results in distinct changes in myocardial work when compared to guideline directed medical therapy
Doctor K. Ljung (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Endothelial dysfunction in HFrEF: investigating the role of red blood cells and guideline directed medical therapy
Doctor U. Reistam (Stockholm, SE)
Abstract Slides Video
Presentation thumbnail
Prognostic impact of angiography-derived index of microcirculatory resistance in patients with dilated cardiomyopathy
Doctor T. Kawamura (Osaka, JP)
Abstract Slides Video
Presentation thumbnail
Changes in left ventricular ejection fraction in patients undergoing transcatheter aortic valve implantation: insights from the COMPARE-TAVI 1 study
Doctor P. Kumarathurai (Odense, DK)
Abstract Slides Video

Access the full session

Session thumbnail
HFrEF: pathophysiological insights

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Impact of sleep apnea syndrome on heart failure
thumbnail
Congress Presentation
Effect of sglt2-inhibitors on polygraphic parameters in elderly patients affected by heart failure and sleep apnea
thumbnail
Congress Presentation
The effect of GLP-1 receptor agonists on obstructive sleep apnea in ambulatory patients with HFpEF, obesity, and type 2 diabetes.

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources